ClinicalTrials.govpublic full text
Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
mesothelioma, immunotoxin, mesothelin, targeted therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853681
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.